Arca
Skip to content

Orthoscan Mobile Di Mini C-Arm

Image-Intensified Fluoroscopic X-Ray System, Mobile. 510(k) K113708, from Orthoscan, Inc. (Scottsdale, AZ). Product code OXO, class 2.

As of Nov 17, 2026, K113708 is an FDA 510(k) held by Orthoscan, Inc., substantially equivalent on Jan 5, 2012 after 20 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Jan 5, 2012
  • Review time: 20 days
  • Recalls: 1
  • Cited as a predicate by: 4 devices

Cited as a Predicate

4 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K113708, newest first; each opens FDA's recall record
StartedReasonStatus
Aug 31, 2017Z-0260-2018OrthoScan Inc. discovered during investigation of a non-standard work flow a non-conformity of the devices. Specifically, the system software allows a user to activate the Digital Zoom feature in the course of taking a…Terminated

Other OXO Clearances

The newest 510(k)s for the same product code; their median review was 152 days; see every OXO device

Record

Type
Traditional, third-party review
Received
Dec 16, 2011
Review panel
Radiology
Regulation
21 CFR 892.1650

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.